Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2026-02-13 @ 9:07 AM
Study NCT ID:
NCT02007720
Status:
TERMINATED
Last Update Posted:
2019-08-02
First Post:
2013-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Heart Failure | View |